62 Cheng W-J, Chuang K-H, Lo Y-J, Chen M, Chen Y-J, Roffler SR, Ho H-O, Lin S-Y, Sheu M-T
69 : 109115 Nadler SG, Strobel HW
[55] designed a bispecific antibody targeting both TGF- and PD-L1, termed BiTP, and demonstrated its therapeutic superiority over monotherapies in triple-negative breast cancer (TNBC)
This interview was edited and condensed for clarity and brevity
In the UK, food supplements are regulated under food law rather than medicines regulation
Keep It Clean: Always use an alcohol swab to clean the skin before injecting